Practice patterns and perceptions of thoracic oncology providers on tobacco use and cessation in cancer patients

Journal of Thoracic Oncology

Volumn 8, Issue 5, 2013, Pages 543-548

  Warren, Graham W ^a   Marshall, James R ^b   Cummings, K Michael ^a   Toll, Benjamin ^c   Gritz, Ellen R ^d   Hutson, Alan ^b   Dibaj, Seyedeh ^b   Herbst, Roy ^c   Dresler, Carolyn ^e  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c YALE CANCER CENTER   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e ARKANSAS DEPARTMENT OF HEALTH   (United States)

Author keywords

Cancer; Cessation; Oncologists; Smoking; Survey; Thoracic; Tobacco

Indexed keywords

ARTICLE; CANCER PATIENT; FOLLOW UP; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PHYSICIAN; PRIORITY JOURNAL; SMOKING CESSATION; TOBACCO;

EID: 84876414570     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318288dc96     Document Type: Article

References (29)

1. Warren GW, Kasza KA, Reid ME, Cummings KM, Marshall JR. Smoking at diagnosis and survival in cancer patients. Int J Cancer 2013;132:401-410.
2. Park SM, Lim MK, Jung K W, et al. Prediagnosis smoking, obesity, insulin resistance, and second primary cancer risk in male cancer survivors: National Health Insurance Corporation Study. J Clin Oncol 2007;25:4835-4843.
3. Driver JA, Yung R, Gaziano JM, Kurth T. Chronic disease in men with newly diagnosed cancer: a nested case-control study. Am J Epidemiol 2010;172:299-308.
4. Jang S, Prizment A, Haddad T, Robien K, Lazovich D. Smoking and quality of life among female survivors of breast, colorectal and endometrial cancers in a prospective cohort study. J Cancer Surviv 2011;5:115-122.
5. Wedlake LJ, Thomas K, Lalji A, et al. Predicting late effects of pelvic radiotherapy: is there a better approach? Int J Radiat Oncol Biol Phys 2010;78:1163-1170.
6. Gajdos C, Hawn MT, Campagna EJ, Henderson WG, Singh JA, Houston T. Adverse effects of smoking on postoperative outcomes in cancer patients. Ann Surg Oncol 2012;19:1430-1438.
7. Parsons A, Daley A, Begh R, Aveyard P. Infuence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 2010;340:b5569.
8. Weaver KE, Rowland JH, Augustson E, Atienza AA. Smoking concordance in lung and colorectal cancer patient-caregiver dyads and quality of life. Cancer Epidemiol Biomarkers Prev 2011;20:239-248.
9. Jerjes W, Upile T, Radhi H, et al. The effect of tobacco and alcohol and their reduction/cessation on mortality in oral cancer patients: short communication. Head Neck Oncol 2012;4:6.
10. Kuri M, Nakagawa M, Tanaka H, Hasuo S, Kishi Y. Determination of the duration of preoperative smoking cessation to improve wound healing after head and neck surgery. Anesthesiology 2005;102:892-896.
11. Mayne ST, Cartmel B, Kirsh V, Goodwin WJ Jr. Alcohol and tobacco use prediagnosis and postdiagnosis, and survival in a cohort of patients with early stage cancers of the oral cavity, pharynx, and larynx. Cancer Epidemiol Biomarkers Prev 2009;18:3368-3374.
12. Bjarnason GA, Mackenzie RG, Nabid A, et al.; National Cancer Institute of Canada Clinical Trials Group (HN3). Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3). Int J Radiat Oncol Biol Phys 2009;73:166-172.
13. Couraud S, Fournel P, Moro-Sibilot D, et al. Professional practice and accessibility to equipment in thoracic oncology. Results of a survey in Rhônes-Alpes region (France). Bull Cancer 2011;98:613-623.
14. Weaver KE, Danhauer SC, Tooze JA, et al. Smoking cessation counseling beliefs and behaviors of outpatient oncology providers. Oncologist 2012;17:455-462.
15. Gritz ER, Carr CR, Rapkin DA, Chang C, Beumer J, Ward PH. A smoking cessation intervention for head and neck cancer patients: trial design, patient accrual, and characteristics. Cancer Epidemiol Biomarkers Prev 1991;1:67-73.
16. Vander Ark W, DiNardo LJ, Oliver DS. Factors affecting smoking cessation in patients with head and neck cancer. Laryngoscope 1997;107:888-892.
17. Schnoll RA, James C, Malstrom M, et al. Longitudinal predictors of continued tobacco use among patients diagnosed with cancer. Ann Behav Med 2003;25:214-222.
18. Gosselin MH, Mahoney MC, Cummings KM, et al. Evaluation of an intervention to enhance the delivery of smoking cessation services to patients with cancer. J Cancer Educ 2011;26:577-582.
19. Gritz ER, Carr CR, Rapkin D, et al. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 1993;2:261-270.
20. Chan Y, Irish JC, Wood SJ, et al. Smoking cessation in patients diagnosed with head and neck cancer. J Otolaryngol 2004;33:75-81.
21. Cooley ME, Wang Q, Johnson BE, et al. Factors associated with smoking abstinence among smokers and recent-quitters with lung and head and neck cancer. Lung Cancer 2012;76:144-149.
22. Duffy SA, Ronis DL, Valenstein M, et al. A tailored smoking, alcohol, and depression intervention for head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 2006;15:2203-2208.
23. Duffy SA, Scheumann AL, Fowler KE, Darling-Fisher C, Terrell JE. Perceived diffculty quitting predicts enrollment in a smoking-cessation program for patients with head and neck cancer. Oncol Nurs Forum 2010;37:349-356.
24. Christensen AJ, Moran PJ, Ehlers SL, Raichle K, Karnell L, Funk G. Smoking and drinking behavior in patients with head and neck cancer: effects of behavioral self-blame and perceived control. J Behav Med 1999;22:407-418.
25. Cooley ME, Finn KT, Wang Q, et al. Health Behaviors, Readiness to Change, and Interest in Health Promotion Programs Among Smokers With Lung Cancer and Their Family Members: A Pilot Study. Cancer Nursing 2012 Jul 11. doi: 10.1097/NCC.0b013e31825e4359
26. Park ER, Japuntich SJ, Rigotti NA, et al. A snapshot of smokers after lung and colorectal cancer diagnosis. Cancer 2012;118:3153-3164.
27. Gritz ER, Dresler C, Sarna L. Smoking, the missing drug interaction in clinical trials: ignoring the obvious. Cancer Epidemiol Biomarkers Prev 2005;14:2287-2293.
28. Goldstein AO, Ripley-Mofftt CE, Pathman DE, Patsakham KM. Tobacco use treatment at the U.S. National Cancer Institute's designated Cancer Centers. Nicotine Tob Res 2013;15:52-58.
29. Cataldo JK, Dubey S, Prochaska JJ. Smoking cessation: an integral part of lung cancer treatment. Oncology 2010;78:289-301.